• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Total number of webinars, teleconferences, and other meetings conducted with Center for Disease Control (CDC), Substance Abuse and Mental Health Services Administration (SAMHSA), and other federal partners in the month

Dictionary: The primary objectives of stakeholder meetings are to share information so that the mission of the Center for Tobacco Products is recognized, understood and supported to the maximum extent possible.

Information is current as of September 30, 2014

Fiscal Year - 2013

Skip graphic and jump to text data

TimeTargetNumber
Oct 2012N/A12
Nov 2012N/A11
Dec 2012N/A3
Jan 2013N/A4
Feb 2013N/A14
Mar 2013N/A7
Apr 2013N/A3
May 2013N/A7
Jun 2013N/A1
Jul 2013N/A5
Aug 2013N/A7
Sep 2013N/A7

FY 2013 Total: 81

Total number of webinars, teleconferences, and other meetings conducted with State, Territorial, Local, and Tribal tobacco control programs and other non-federal government partners and stakeholders in the month

Fiscal Year - 2013

Skip graphic and jump to text data

TimeTargetNumber
Oct 2012N/A12
Nov 2012N/A6
Dec 2012N/A13
Jan 2013N/A11
Feb 2013N/A9
Mar 2013N/A1
Apr 2013N/A3
May 2013N/A0
Jun 2013N/A7
Jul 2013N/A1
Aug 2013N/A0
Sep 2013N/A2

FY 2013 Total: 65

Total number of webinars, teleconferences, and other meetings conducted with non-governmental stakeholders in the month

Fiscal Year - 2013

Skip graphic and jump to text data

TimeTargetNumber
Oct 2012N/A18
Nov 2012N/A7
Dec 2012N/A1
Jan 2013N/A3
Feb 2013N/A2
Mar 2013N/A3
Apr 2013N/A9
May 2013N/A9
Jun 2013N/A13
Jul 2013N/A4
Aug 2013N/A13
Sep 2013N/A6

FY 2013 Total: 88

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.